LLNL’s high throughput method involves proteome-wide screening for linear B-cell epitopes using native proteomes isolated from a pathogen of interest and convalescent sera from immunized animals. LLNL researchers have applied their newly developed generalizable screening method to the identification of pathogenic bacteria by screening linear B-cell epitopes in the proteome of Francisella…
Keywords
- Show all (112)
- Instrumentation (38)
- Diagnostics (13)
- Imaging Systems (9)
- Photoconductive Semiconductor Switches (PCSS) (9)
- Semiconductors (6)
- Therapeutics (5)
- Brain Computer Interface (BCI) (4)
- Optical Switches (4)
- Power Electronics (3)
- Sensors (3)
- Computing (2)
- Electric Grid (2)
- MEMS Sensors (2)
- Optical Sensors (2)
- Particle Accelerators (2)
- Rare Earth Elements (REEs) (2)
- Spectrometers (2)
- Additive Manufacturing (1)
- Precision Engineering (1)
- (-) Vaccines (2)
Technology Portfolios
Image
![Immunoproteomic workflow to identify antigenic peptides.](/sites/default/files/styles/scale_exact_400x400_/public/2023-04/Immunoproteomic_workflow.png?itok=unIjnCCK)
High throughput discovery of linear B-cell epitopes for the development of vaccines and therapeutics
Image
![nanolipoprotein particles](/sites/default/files/styles/scale_exact_400x400_/public/2022-06/nanolipoprotein%20particles.jpg?itok=nQgwpZE3)
LLNL has developed a novel process of production, isolation, characterization, and functional re-constitution of membrane-associated proteins in a single step. In addition, LLNL has developed a colorimetric assay that indicates production, correct folding, and incorporation of bR into soluble nanolipoprotein particles (NLPs).
LLNL has developed an approach, for formation of NLP/…